MUMBAI, India, July 24 -- Intellectual Property India has published a patent application (202418063683 A) filed by Nymox Corporation on August 23, 2024, for Method Of Enhancing The Therapeutic Efficacy Of Fexapotide Triflutate In Treating Luts.
Inventor includes Averback, Paul.
The application for the patent was published on July 17, 2026, under issue no. 29/2026.
Abstract: Disclosed are methods of enhancing the therapeutic efficacy of Fexapotide Triflutate (TF) in treating LUTS, both irritative and obstructive, that include administering a composition comprising FT at least twice over a period spanning more than one year. The methods are capable of providing an enhanced therapeutic effect in treating nocturia, and in improving urinary flow, when compared to the therapeutic effect achieved by administration of the same or twice the total amount of FT administered.
Disclaimer: Curated by HT Syndication.
